WINSUNBIO
839729
HIGO
872351
DRIVE
838275
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -14.77%8.8B | -17.70%9.04B | -29.52%7.44B | 3.57%10.15B | -7.91%10.32B | -1.82%10.98B | 726.66%10.56B | 886.12%9.8B | 471.81%11.21B | --11.18B |
Notes receivable and accounts receivable | 52.62%2.28B | -25.98%1B | 18.63%1.4B | -14.03%1.28B | 19.92%1.49B | 8.17%1.36B | 7.84%1.18B | 115.24%1.48B | 265.27%1.24B | --1.25B |
-Notes receivable | ---- | ---- | ---- | ---- | ---- | 352.03%154.48M | -64.56%69.92M | --373.4M | 301.98%272.54M | --34.17M |
-Accounts receivable | 52.62%2.28B | -16.46%1B | 26.08%1.4B | 14.86%1.28B | 53.59%1.49B | -1.47%1.2B | 23.72%1.11B | 61.12%1.11B | 256.13%970.67M | --1.22B |
Other receivables (including interest and dividends) | 53.98%26.77M | 68.79%26.14M | 118.26%29.08M | 115.06%24.19M | 61.28%17.39M | 36.60%15.48M | 28.58%13.32M | 5.31%11.25M | 3.87%10.78M | --11.34M |
-Other receivable | 53.98%26.77M | ---- | 118.26%29.08M | ---- | 61.28%17.39M | ---- | 28.58%13.32M | ---- | 3.87%10.78M | ---- |
Advance payment | -48.07%1.24B | 19.55%2.21B | 65.36%3.09B | 80.36%2.61B | 154.81%2.39B | 53.04%1.85B | 118.24%1.87B | 111.90%1.45B | 294.83%937.32M | --1.21B |
Inventories | 405.09%5.43B | 467.71%3.9B | 177.84%2.46B | 54.64%1.71B | -1.93%1.07B | -38.48%686.24M | -14.99%883.74M | -8.13%1.11B | -2.59%1.1B | --1.12B |
Receivable financing | ---- | --451K | --103.57M | --1.25M | --32.89M | ---- | ---- | ---- | ---- | ---- |
Non-current assets due within one year | 0.00%50.7M | -77.63%50.7M | -66.33%50.7M | -88.01%50.7M | -87.58%50.7M | 793.87%226.6M | 1,087.85%150.56M | --422.74M | --408.15M | --25.35M |
Other current assets | 592.90%391.21M | 1,617.32%352.47M | 360.46%212.09M | 72.79%134.75M | 22.56%56.46M | -87.15%20.52M | 37.92%46.06M | -59.40%77.98M | -76.77%46.07M | --159.68M |
Total current assets | 17.98%18.21B | 9.53%16.58B | 0.56%14.79B | 11.21%15.96B | 3.23%15.43B | 1.19%15.14B | 239.85%14.7B | 280.31%14.35B | 286.18%14.95B | --14.96B |
Non Current assets | ||||||||||
Other equity investment | 0.00%20M | 0.00%20M | 0.00%20M | --20M | --20M | --20M | --20M | ---- | ---- | ---- |
Other non-current financial assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --217.63M |
Fixed assets | 54.62%537.09M | ---- | 26.35%407.06M | ---- | 27.73%347.36M | ---- | 69.67%322.17M | ---- | 153.38%271.94M | ---- |
Intangible assets | -7.21%4.12B | 19.43%4.43B | 8.34%4.22B | 3.80%4.21B | 4.65%4.44B | -16.09%3.71B | -12.35%3.9B | -8.28%4.06B | 11.21%4.25B | --4.42B |
Development expenditure | -44.47%260.45M | -93.54%78.16M | -49.47%465.36M | -21.27%564.25M | -11.12%468.99M | 413.53%1.21B | 283.06%920.99M | 134.47%716.66M | -45.57%527.64M | --235.47M |
Long deferred expense | 130.72%110.53M | 205.42%110.91M | 517.02%118.76M | 391.06%90.18M | 144.03%47.91M | 164.43%36.31M | 27.63%19.25M | 20.56%18.36M | 31.29%19.63M | --13.73M |
Deferred tax assets | 239.56%49.7M | -13.14%15.38M | -35.90%14.28M | -28.26%17.73M | 22.72%14.64M | 115.10%17.71M | 204.63%22.28M | 229.73%24.71M | 87.26%11.93M | --8.23M |
Usufruct assets | 92.34%101.46M | 73.87%103.63M | -18.53%46.62M | -28.21%45.67M | -24.66%52.75M | -21.99%59.61M | 2.13%57.23M | 42.07%63.62M | 43.73%70.01M | --76.41M |
Other non current assets | 148.18%5.15B | 65.83%5.31B | 46.23%4.25B | -22.98%2.09B | 12.87%2.08B | 84.17%3.2B | 82.27%2.91B | 92.95%2.72B | 30.40%1.84B | --1.74B |
Total non current assets | 38.58%10.35B | 21.52%10.48B | 16.90%9.55B | -6.27%7.37B | 6.94%7.47B | 24.64%8.62B | 20.72%8.17B | 20.42%7.86B | 6.06%6.99B | --6.92B |
Total assets | 24.70%28.56B | 13.88%27.06B | 6.39%24.33B | 5.02%23.33B | 4.41%22.9B | 8.60%23.76B | 106.19%22.87B | 115.61%22.21B | 109.75%21.93B | --21.88B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | 414.29%1.8B | 214.29%2.2B | 100.00%400M | --350M | 75.00%350M | 29.63%700M | -62.96%200M | ---- | 33.33%200M | --540M |
Notes payable and accounts payable | 128.53%735.37M | 110.22%649M | 198.74%830.06M | 19.57%397.37M | -6.04%321.78M | -4.40%308.73M | 33.86%277.85M | 112.75%332.32M | 17.26%342.45M | --322.94M |
-Accounts payable | 128.53%735.37M | 110.22%649M | 198.74%830.06M | 19.57%397.37M | -6.04%321.78M | -4.40%308.73M | 33.86%277.85M | 112.75%332.32M | 17.26%342.45M | --322.94M |
Contract liabilities | 31,611.25%903.47M | --15M | --15M | --2.85M | --2.85M | ---- | ---- | ---- | ---- | --4.7M |
Salaries payable | 39.67%706.87M | 58.04%530.19M | 40.00%461.45M | 63.65%351.74M | 47.77%506.12M | 49.53%335.48M | 74.90%329.6M | 57.67%214.94M | 26.84%342.5M | --224.35M |
Taxs payable | -31.63%106.82M | -35.14%49.91M | -27.75%78.58M | 25.75%106.59M | 69.56%156.25M | 81.47%76.96M | 168.88%108.77M | 140.10%84.77M | 32.71%92.15M | --42.41M |
Other payable (including interest and dividends) | 8.65%13.6M | -76.70%3.38M | -82.86%2.67M | -76.36%3.62M | 100.45%12.52M | 281.55%14.5M | 492.42%15.57M | 874.34%15.31M | 124.14%6.25M | --3.8M |
-Other payable | 8.65%13.6M | ---- | -82.86%2.67M | ---- | 100.45%12.52M | ---- | 492.42%15.57M | ---- | 124.14%6.25M | ---- |
Non current liabilities due within one year | 172.07%122.07M | -58.22%25.87M | -37.89%29.06M | -94.01%23.24M | -88.40%44.87M | -85.28%61.9M | -88.76%46.8M | 279.80%388.24M | -33.72%386.66M | --420.42M |
Other current liabilities | ---- | --900K | --900K | --170.94K | --170.94K | ---- | ---- | ---- | ---- | --281.89K |
Total current liabilities | 214.67%4.39B | 131.99%3.47B | 85.75%1.82B | 19.31%1.24B | 1.79%1.39B | -3.94%1.5B | -33.31%978.58M | -11.90%1.04B | -12.30%1.37B | --1.56B |
Current liabilities | ||||||||||
Long term account payable | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
Specific account payable | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%1.65B | ---- | -12.23%1.65B | ---- |
Estimate liabilities | 20.85%24.08M | 462.40%25.57M | 430.22%24.11M | 427.03%25.57M | 350.66%19.93M | 159.86%4.55M | 122.01%4.55M | 78.48%4.85M | 135.58%4.42M | --1.75M |
Deferred tax liabilities | ---- | ---- | ---- | ---- | ---- | 259.49%9.51M | 304.51%9.51M | 575.33%13.91M | 69.84%3.01M | --2.64M |
Long term deferred income | 85.27%515.19M | 178.81%466.05M | 58.22%271.85M | 63.20%264.08M | 84.75%278.08M | 6.92%167.15M | 4.48%171.82M | -4.72%161.82M | -15.33%150.52M | --156.34M |
Lease liabilities | 162.03%81.14M | 252.05%76.61M | -38.78%20.8M | -37.66%24.74M | -33.50%30.97M | -60.21%21.76M | -11.88%33.98M | 27.33%39.68M | 47.48%46.57M | --54.69M |
Total non current liabilities | 27.90%1.52B | -42.47%1.57B | -51.99%1.32B | -48.50%1.31B | -49.11%1.19B | 15.63%2.72B | 7.54%2.74B | -1.80%2.55B | -11.37%2.33B | --2.36B |
Total liabilities | 128.76%5.91B | 19.43%5.04B | -15.73%3.13B | -28.92%2.55B | -30.29%2.58B | 7.84%4.22B | -7.39%3.72B | -4.95%3.59B | -11.72%3.7B | --3.91B |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%2.32B | 0.00%2.32B | 0.00%2.32B | 0.00%2.32B | 0.00%2.32B | 0.00%2.32B | 14.82%2.32B | 14.82%2.32B | 14.82%2.32B | --2.32B |
Capital reserve funds | 1.20%14.52B | 3.39%14.5B | 3.56%14.46B | 3.68%14.41B | 3.70%14.35B | 1.83%14.03B | 307.36%13.96B | 313.40%13.9B | 319.95%13.84B | --13.78B |
Surplus reserve funds | 92.97%101.92M | 391.24%52.81M | 391.24%52.81M | 391.68%52.81M | 391.24%52.81M | --10.75M | --10.75M | --10.74M | --10.75M | ---- |
Retained profit | 81.03%3.63B | 94.20%3.28B | 78.00%2.6B | 105.30%2.3B | 128.37%2.01B | 128.65%1.69B | 160.46%1.46B | 387.46%1.12B | 922.92%878.83M | --738.02M |
Less:Treasury stock | 1,007.48%332.39M | --332.39M | --230.02M | --30.01M | --30.01M | ---- | ---- | ---- | ---- | ---- |
Shareholders equity without minority interests | 8.26%20.25B | 9.83%19.82B | 8.17%19.21B | 9.80%19.06B | 9.69%18.71B | 7.20%18.05B | 195.35%17.76B | 209.00%17.35B | 215.47%17.05B | --16.84B |
Minority interests | 48.67%2.4B | 47.20%2.2B | 42.86%1.99B | 35.56%1.72B | 37.21%1.62B | 32.26%1.49B | 30.75%1.39B | 39.12%1.27B | 37.54%1.18B | --1.13B |
Total shareholder equity | 11.48%22.65B | 12.68%22.02B | 10.69%21.2B | 11.56%20.78B | 11.46%20.32B | 8.77%19.54B | 170.60%19.15B | 185.26%18.62B | 191.15%18.23B | --17.97B |
Total liabilityies and equity | 24.70%28.56B | 13.88%27.06B | 6.39%24.33B | 5.02%23.33B | 4.41%22.9B | 8.60%23.76B | 106.19%22.87B | 115.61%22.21B | 109.75%21.93B | --21.88B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | -- | -- |
Auditor | -- | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.